Green fluorescent protein fused to peptide agonists of two dissimilar G protein‐coupled receptors: novel ligands of the bradykinin B 2 (rhodopsin family) receptor and parathyroid hormone PTH 1 (secretin family) receptor-Reference-Cited by-同舟云学术

Green fluorescent protein fused to peptide agonists of two dissimilar G protein‐coupled receptors: novel ligands of the bradykinin B 2 (rhodopsin family) receptor and parathyroid hormone PTH 1 (secretin family) receptor

Published:2013-10 Issue:1 Volume:1 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Charest‐Morin Xavier¹,Fortin Jean‐Philippe²,Bawolak Marie‐Thérèse¹,Lodge Robert³,Marceau François¹

Affiliation:

1. Centre de recherche en rhumatologie et immunologie CHU de Québec, Université Laval Québec Canada G1V 4G2

2. Pfizer's Cardiovascular and Metabolic Diseases Research Unit Cambridge Massachusetts 02139

3. Laboratory of Human Retrovirology Institut de recherches cliniques de Montréal Montreal Québec Canada H2W 1R7

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.4

Reference35 articles.

1. Guide to Receptors and Channels (GRAC), 5th edition

2. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) Is an Inactivation-Resistant Agonist of the Bradykinin B2Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): Pharmacologic Profile and Effective Induction of Receptor Degradation

3. Bradykinin B2 receptor-mediated transport into intact cells: Anti-receptor antibody-based cargoes

4. Prolonged signalling and trafficking of the bradykinin B2 receptor stimulated with the amphibian peptide maximakinin: Insight into the endosomal inactivation of kinins

5. Attenuation of green fluorescent protein half-life in mammalian cells

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development, Optimization, and Validation of an in vitro Cell-Based Bioassay to Determine the Biological Activity of Teriparatide (PTH1–34);Pharmaceutical Fronts;2024-08-06

2. Development, Optimization and Validation of an in Vitrocell-Based Bioassay Method for Teriparatide (Pth1-34);2023

3. Recombinant PTH modification: A new strategy for a multifunctional CaP material to enhance bone regeneration;Composites Part B: Engineering;2022-12

4. Parathyroid hormone and its related peptides in bone metabolism;Biochemical Pharmacology;2021-10

5. A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors;Pharmaceuticals;2020-08-17